Skip to main content
TEYI PHARMACEUTICAL GROUP CO.,LTD logo

TEYI PHARMACEUTICAL GROUP CO.,LTD — Investor Relations & Filings

Ticker · 002728 ISIN · CNE100001WK6 LEI · 300300ZUIZCFPGQWOZ61 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,596 across all filing types
Latest filing 2016-12-05 Capital/Financing Update
Country CN China
Listing Shenzhen Stock Exchange 002728

About TEYI PHARMACEUTICAL GROUP CO.,LTD

https://www.tczy.com.cn

TEYI PHARMACEUTICAL GROUP CO.,LTD. specializes in the research, development, manufacturing, and distribution of pharmaceutical products. The company's portfolio primarily consists of Chinese patent medicines and chemical drug preparations. Its flagship product, Zhike Bao Tablets, is widely recognized for treating chronic bronchitis and cough-related ailments. Beyond respiratory health, the group produces a diverse range of medications covering cardiovascular diseases, gastrointestinal disorders, and anti-infective treatments. Teyi Pharmaceutical operates modern production facilities and maintains a robust distribution network to serve healthcare providers and pharmacies. The company emphasizes the integration of traditional medicinal knowledge with modern pharmaceutical technology to enhance product efficacy and safety.

Recent filings

Filing Released Lang Actions
独立董事关于变更部分募集资金用于永久性补充流动资金的独立意见
Capital/Financing Update Classification · 95% confidence The document is a formal independent director opinion regarding the change in use of part of the raised funds to permanently supplement working capital. It references compliance with stock exchange listing rules and company articles but does not contain financial statements or detailed financial data. The document length is short (582 characters) and it is a standalone opinion letter, not a full report or announcement of voting results. It is not a certification or a general regulatory filing but a specific independent opinion on a capital use matter. This fits best under Capital/Financing Update (CAP) as it relates to changes in the use of raised capital funds.
2016-12-05 Chinese
关于第三届董事会第十次会议决议的公告
Board/Management Information Classification · 95% confidence The document is a formal announcement from the board of directors of 特一药业集团股份有限公司 regarding the resolutions passed at the third session of the tenth meeting of the third board of directors. It details the meeting date, attendance, and the resolutions passed, including the change in use of some raised funds and the proposal to convene an extraordinary general meeting. The document is an official announcement of board meeting decisions, not a full report or financial statement. It does not contain financial data or detailed management discussion but rather the outcomes of a board meeting. Therefore, it fits the category of Board/Management Information (MANG). The document length is short (1816 characters), and it is not a report publication announcement or regulatory filing. Hence, the classification is MANG with high confidence.
2016-12-05 Chinese
关于归还用于暂时补充流动资金的闲置募集资金的公告
Capital/Financing Update Classification · 95% confidence The document is a company announcement regarding the return of temporarily used idle raised funds to supplement working capital. It details the timeline and amounts of funds returned to the dedicated fundraising account. The document is short (1015 characters) and focuses on a specific capital management update rather than a full financial report or earnings release. It does not contain financial statements or detailed financial analysis. This fits the description of a Capital/Financing Update (CAP) as it relates to the company's financing activities and capital structure changes, specifically the use and return of raised funds.
2016-11-27 Chinese
公司章程（2016年10月）
Governance Information Classification · 100% confidence The document is titled as the "章程" (Articles of Association or Company Bylaws) of 特一药业集团股份有限公司, dated October 2016. It contains detailed provisions on company organization, shareholder rights, board and management structure, share issuance, shareholder meetings, voting procedures, and other governance matters. It is a comprehensive governance document outlining the internal rules and regulations of the company rather than a financial report, announcement, or meeting minutes. There is no indication that this is an announcement or a report publication notice; it is the actual governance charter of the company. Therefore, the document fits the category of Governance Information (CGR).
2016-11-07 Chinese
关于变更公司名称、证券简称及组建企业集团的公告
Regulatory Filings Classification · 95% confidence The document is an official announcement from Guangdong Taicheng Pharmaceutical Co., Ltd. regarding the change of the company name, securities abbreviation, and the establishment of a corporate group. It includes details about board and shareholder meeting approvals, regulatory compliance, and the effective date of the name change. There are no financial statements, earnings data, or detailed financial analysis present. The document is relatively short (1388 characters) and serves as a formal notification of corporate changes rather than a report or detailed filing. This fits the category of a Regulatory Filing (RNS), which covers general regulatory announcements and compliance documents that do not fit other specific categories.
2016-11-06 Chinese
2016年第二次临时股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a detailed announcement of the resolutions passed at the 2016 second extraordinary shareholders' meeting of Guangdong Taicheng Pharmaceutical Co., Ltd. It includes voting results on various proposals related to a non-public stock issuance, changes in company name, amendments to the articles of association, and other corporate governance matters. The document contains detailed voting statistics and legal opinions confirming the validity of the meeting and resolutions. It is not a financial report, earnings release, or management discussion, but rather an official announcement of shareholder voting results. Therefore, it fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA). The document length and content confirm it is not a mere announcement of a report but the actual voting results disclosure.
2016-10-25 Chinese

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.